Site and number of metastases predict outcomes in avelumab maintenance for advanced UC: results from meet-URO 25.
Saved in:
| Title: | Site and number of metastases predict outcomes in avelumab maintenance for advanced UC: results from meet-URO 25. |
|---|---|
| Authors: | Roviello G; Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Viale Pieraccini, 6, 50139, Florence, Italy. giandomenico.roviello@unifi.it., Gambale E; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.; Clinical Oncology, Careggi University Hospital, Florence, Italy., De Gennaro Aquino I; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.; Clinical Oncology, Careggi University Hospital, Florence, Italy., Maruzzo M; Oncology 3 Unit, Department of Oncology, Istituto Oncologico Veneto IOV - IRCCS, Padua, Italy., Messina C; Clinical Oncology, Ospedale Arnas Civico, Palermo, Italy., Vascotto IA; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.; Clinical Oncology, Careggi University Hospital, Florence, Italy., Rossi V; Clinical Oncology, Careggi University Hospital, Florence, Italy., Bimbatti D; Medical Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, Padua, Italy., Erbetta E; Oncology 3 Unit, Department of Oncology, Istituto Oncologico Veneto IOV - IRCCS, Padua, Italy.; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy., Messina M; Clinical Oncology, Ospedale Arnas Civico, Palermo, Italy., Mennitto A; Division of Oncology, University Hospital Maggiore della Carità, Novara, Italy., Rebuzzi SE; Medical Oncology Unit 2, Ospedale Molinette Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino Corso, Bramante 88, 10126, Turin, Italy., Nasso C; Medical Oncology, Ospedale Santa Corona, 17027, Pietra Ligure, Italy., Mercinelli C; Department of Medical Oncology, IRCCS San Raffaele Hospital, Comprehensive Cancer Center, and Vita-Salute San Raffaele University, Milan, Italy., Catalano M; Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Viale Pieraccini, 6, 50139, Florence, Italy., Maiorano BA; Medical Oncology Department, IRCCS San Raffaele Hospital, Milan, Italy., Fanelli M; Department of Oncology, University Hospital of Udine, Udine, Italy., Sorarù M; Ospedale di Camposampiero, U.O. Oncologia, Camposampiero, Italy., Scolari F; Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy., Mela MM; Clinical Oncology, Careggi University Hospital, Florence, Italy., Galli L; Medical Oncology Unit 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy., Salfi A; Medical Oncology Unit 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy., Rizzo M; Oncologia Medica Universitaria Azienda Ospedaliera Universitaria Consorziale Policlinico di Bari Piazza Giulio Cesare, 11, 70124, Bari, Italy., Puglisi S; IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Orlando V; Department of Oncology, Ospedale Maggiore, Trieste, Italy., Fornarini G; IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Rametta A; Genitourinary Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian 1, Milan, Italy., Giannatempo P; Genitourinary Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian 1, Milan, Italy., Cerbone L; Medical Oncology 1, IRCCS National Cancer Institute Regina Elena, Rome, Italy., Doni L; Clinical Oncology, Careggi University Hospital, Florence, Italy., Pillozzi S; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.; Clinical Oncology, Careggi University Hospital, Florence, Italy., Antonuzzo L; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.; Clinical Oncology, Careggi University Hospital, Florence, Italy. |
| Source: | Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2026 Feb 14; Vol. 75 (3), pp. 79. Date of Electronic Publication: 2026 Feb 14. |
| Publication Type: | Journal Article; Multicenter Study; Observational Study |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-0851 |
|---|---|
| DOI: | 10.1007/s00262-025-04270-2 |
